Morphea Profunda Treated with AFT – A Case Report Interview
Morphea profunda. To the dermatologist, these words conjure images of hyperpigmented to violaceous, indurated, bound down atrophic plaques. We describe these lesions in our specialty’s vernacular, so that those we are conversing with can often surmise the diagnosis before even seeing the affected patient. But to the patient, it is the language of the diagnosis itself that has the most meaning. M …
Morphea profunda. To the dermatologist, these words conjure images of hyperpigmented to violaceous, indurated, bound down atrophic plaques. We describe these lesions in our specialty’s vernacular, so that those we are conversing with can often surmise the diagnosis before even seeing the affected patient. But to the patient, it is the language of the diagnosis itself that has the most meaning. M … Continue reading "Morphea Profunda Treated with AFT – A Case Report Interview"
What would this lesion show histologically?
A. A proliferation of basaloid cells with small ducts
B. A grenz zone with a lot of inflammatory cells and globi
C. Well formed tuberculoid granulomas in a linear pattern
D. Scattered comedo-like cysts
E. Acanthosis and neutrophilic infiltrate
To find out the correct answer and read the explanation, click here.
Brought to you by our … 
Well+Good recently published an article asking if hair loss supplements actually work.
For an expert opinion, I consulted Crystal Aguh, MD, Director of the Ethnic Skin Program and Assistant Professor in the Department of Dermatology at Johns Hopkins University School of Medicine, Baltimore, MD.
What is the theory behind hair supplements?
Hair supplements are designed to create an ideal nu … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, is excited to share a new video series where dermatology key opinion leaders share important updates and pearls on a variety of medical, surgical, and aesthetic dermatology topics.
First up is Dr. Amy McMichael, Professor and Chair of Dermatology at the Wake Forest University School of Medicine, sharing … 
JDD Author and Senior Associate Editor, Dr. Leon Kircik, dives into the controversial and confusing landscape of in-office medication compounding.
In-office compounding, once part and parcel of dermatologic practice, has become increasingly controversial—and confusing. As a result of legitimate public health concerns, FDA scrutiny began with compounding facilities. Unfortunately, regulatory f … 